Log in to save to my catalogue

Prevalence and outcomes of patients developing heparin-induced thrombocytopenia during extracorporea...

Prevalence and outcomes of patients developing heparin-induced thrombocytopenia during extracorporea...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2699933086

Prevalence and outcomes of patients developing heparin-induced thrombocytopenia during extracorporeal membrane oxygenation

About this item

Full title

Prevalence and outcomes of patients developing heparin-induced thrombocytopenia during extracorporeal membrane oxygenation

Publisher

San Francisco: Public Library of Science

Journal title

PloS one, 2022-08, Vol.17 (8), p.e0272577

Language

English

Formats

Publication information

Publisher

San Francisco: Public Library of Science

More information

Scope and Contents

Contents

Unfractionated heparin (UFH) is the commonly used anticoagulant to prevent clotting of the ECMO circuit and thrombosis of the cannulated vessels. A side effect of UFH is heparin-induced thrombocytopenia (HIT). Little is known about HIT during ECMO and the impact of changing anticoagulation in ECMO patients with newly diagnosed HIT. The aim of the s...

Alternative Titles

Full title

Prevalence and outcomes of patients developing heparin-induced thrombocytopenia during extracorporeal membrane oxygenation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2699933086

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2699933086

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0272577

How to access this item